Experience with Triple-Drug Therapy in a Pharmacological Erection Program
- 1 December 1993
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 150 (6), 1822-1824
- https://doi.org/10.1016/s0022-5347(17)35905-0
Abstract
A group of 170 impotent men achieved usable erections during a 26-month period with a combination of papaverine, phentolamine and prostaglandin E1 (triple-drug therapy) injected intracorporeally. Of the patients 146 elected to enter a pharmacological erection program using this combination. Patient age ranged from 24 to 85 years and the average duration on the program was 11.2 months. Average injection volume was 0.36 cc per injection (range 0.1 to 1). Among those patients managed by our nurse clinician, only 3 episodes of priapism were encountered (1.7%). Scarring was documented in 7 of 170 patients (4.2%) 1 week to 21 months after starting the injections. Pain was encountered in 6 of 170 patients (3.5%). A superior dose response coupled with a low incidence of priapism, pain and scarring have led us to use triple-drug therapy as our agent of choice in the pharmacological management of erectile dysfunction.Keywords
This publication has 10 references indexed in Scilit:
- Intracavernous Self-Injection of Vasoactive Drugs in the Treatment of Impotence: 8-Year Experience with 615 CasesJournal of Urology, 1991
- Treatment of Persistent Penile Erection and Priapism Using TerbutalineJournal of Urology, 1989
- The pH Analysis of Papaverine-Phentolamine and Prostaglandin E 1 for Pharmacologic ErectionJournal of Urology, 1989
- Side Effects of Self-Administration of Intracavernous Papaverine and Phentolamine for the Treatment of ImpotenceJournal of Urology, 1989
- Effects of Prostaglandin E1 on Penile Erection and Erectile FailureJournal of Urology, 1987
- Physiology of Erection and Pharmacological Management of ImpotenceJournal of Urology, 1987
- STUDIES ON MALE SEXUAL IMPOTENCE REPORT 18The Japanese Journal of Urology, 1986
- Auto-Injection of the Corpus Cavernosum with a Vasoactive Drug Combination for Vasculogenic ImpotenceJournal of Urology, 1985
- Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile FailureAngiology, 1984
- Cavernosal Alpha-Blockade: A New Technique for Investigating and Treating Erectile ImpotenceThe British Journal of Psychiatry, 1983